Optimal use of lipid-lowering therapy after acute coronary syndromes: A Position Paper endorsed by the International Lipid Expert Panel (ILEP)-Reference-Cited by-同舟云学术

Optimal use of lipid-lowering therapy after acute coronary syndromes: A Position Paper endorsed by the International Lipid Expert Panel (ILEP)

Published:2021-04 Issue: Volume:166 Page:105499
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Banach Maciej,Penson Peter E.,Vrablik Michal,Bunc Matjaz,Dyrbus Krzysztof,Fedacko Jan,Gaita Dan,Gierlotka Marek,Jarai Zoltan,Magda Stefania Lucia,Margetic Eduard,Margoczy Roman,Durak-Nalbantic Azra,Ostadal Petr,Pella Daniel,Trbusic Matias,Udroiu Cristian Alexandru,Vlachopoulos Charalambos,Vulic Dusko,Fras Zlatko,Dudek Dariusz,Reiner Željko

Publisher

Elsevier BV

Subject

Pharmacology

Reference45 articles.

1. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study;Roth;J. Am. Coll. Cardiol.,2020

2. European Society of Cardiology: Cardiovascular Disease Statistics 2019;Timmis;Eur. Heart J.,2020

3. Mapping interventional cardiology in Europe: the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Atlas Project;Barbato;Eur. Heart J.,2020

4. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel;Ference;Eur. Heart J.,2017

5. Interpretation of the evidence for the efficacy and safety of statin therapy;Collins;Lancet,2016

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of fixed-dose combinations for cardiovascular indications from 2018 to 2023: a nationwide population-based study;Journal of Hypertension;2024-06-11

2. The Evaluation of Lipid-Lowering Treatment in Patients with Acute Coronary Syndrome in a Hungarian Invasive Centre in 2015, 2017, and during the COVID-19 Pandemic—The Comparison of the Achieved LDL-Cholesterol Values Calculated with Friedewald and Martin–Hopkins Methods;Journal of Clinical Medicine;2024-06-11

3. Guía latinoamericana de recomendaciones al egreso de un síndrome coronario agudo;Archivos de Cardiología de México;2024-06-05

4. Inclisiran: the preclinical discovery and development of a novel therapy for the treatment of atherosclerosis;Expert Opinion on Drug Discovery;2024-05-28

5. Could siRNA therapeutics change the way we treat dyslipidemia?;Expert Opinion on Biological Therapy;2024-05-03